-
BREAKING: InterDigital, Xiaomi renew patent license agreement without litigation; five-year term; cellular, WiFi, HEVC patents included
Read more: BREAKING: InterDigital, Xiaomi renew patent license agreement without litigation; five-year term; cellular, WiFi, HEVC patents includedInterDigital has signed a new major license agreement with a party that is undisclosed, but whose name can be deduced from previously available information.
-
Contrasting appellate tactics show Amazon feels protected by UK ASI against InterDigital’s Munich AILI, but is scared of UPC sua sponte sanctions
Read more: Contrasting appellate tactics show Amazon feels protected by UK ASI against InterDigital’s Munich AILI, but is scared of UPC sua sponte sanctionsThere are two striking differences between Amazon’s UPC and Munich appeals of InterDigital’s anti-interim-license injunctions.
-
BREAKING: Heath Hoglund, who left Via last month, joins Sisvel as Chief IP Officer
Read more: BREAKING: Heath Hoglund, who left Via last month, joins Sisvel as Chief IP OfficerThis is Sisvel’s highest-profile external hire.
-
Tesla should learn from Amazon-InterDigital, take an Avanci 5G license: even if its long-shot UKSC appeal succeeded, it wouldn’t help
Read more: Tesla should learn from Amazon-InterDigital, take an Avanci 5G license: even if its long-shot UKSC appeal succeeded, it wouldn’t helpFor cross-jurisdictional reasons, Tesla should give up on its UK case against Avanci and InterDigital, in which it lost the first two rounds.
-
UPC President denies Amazon motion to stay enforcement of InterDigital’s anti-interim-license injunction; Amazon may already be in breach
Read more: UPC President denies Amazon motion to stay enforcement of InterDigital’s anti-interim-license injunction; Amazon may already be in breachThis does not mean that Amazon’s appeal will necessarily fail, but Amazon could now face contempt proceedings any day.
-
CJEU publishes European Parliament’s suit against European Commission’s decision to withdraw SEP Regulation
Read more: CJEU publishes European Parliament’s suit against European Commission’s decision to withdraw SEP RegulationThe Commission “prematurely” brought the legislative procedure to an end without legitimate grounds supported by cogent evidence and arguments for doing so, the EP has alleged.
-
China’s top court grants Novo Nordisk win over key Ozempic patent
Read more: China’s top court grants Novo Nordisk win over key Ozempic patentChina’s Supreme People’s Court has upheld a lower court’s decision recognizing the validity of Novo Nordisk’s compound patent related to semaglutide, which is found in the company’s blockbuster drugs Ozempic, Wegovy, and Rybelsus.


